• J Clin Pharmacol · May 1980

    Comparative Study Clinical Trial

    Long-term safety of zomepirac: a double-blind comparison with aspirin in patients with osteoarthritis.

    • G E Ruoff, S Y Andelman, and J J Cannella.
    • J Clin Pharmacol. 1980 May 1; 20 (5-6 Pt 2): 377-84.

    AbstractZomepirac at daily doses of 400 to 600 mg was well tolerated and provided continuing effective analgesia in the relief of chronic pain associated with osteoarthritis. In this long-term safety study, patients treated with zomepirac had significantly fewer adverse reactions and fewer limiting adverse reactions than did patients treated with aspirin. Thus zomepirac, which has previously shown efficacy in single-dose studies as well as good patient acceptability and efficacy in circumstances typical of clinical practice, has been found in this study to compare favorably to aspirin in a long-term (12-week) study in 238 patients with chronic pain secondary to osteoarthritis.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…